Dr Reddys Laboratories Share Price Today - Live Blog for July 28, 2025

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.14%, and as of now, it's trading at ₹1,287.60 per share. This upward trajectory is attracting keen interest from investors.

After a -0.03% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,288.00. The stock has a PE ratio of 18.7700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.03% drop, and it's now trading at ₹1,288.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.12%, reaching the current market price of ₹1,288.50. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's stock has surged by 0.14%, and it is currently trading at ₹1,280.65. Additionally, the stock maintains a PE ratio of 18.7700, while the industry PE is 35.6163.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.14%, and as of now, it's trading at ₹1,280.65 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd's stock has surged by 0.03%, and it is currently trading at ₹1,278.90. Additionally, the stock maintains a PE ratio of 18.7700, while the industry PE is 35.6163.

Dr Reddys Laboratories Ltd stock price decreased by -0.10%, with the current market value at ₹1,278.55 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

After a significant 0.03% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,279.30 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd observed a -0.06% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,278.00. The stock has a PE ratio of 18.7700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price has declined by -0.06%, and it's currently trading at ₹1,278.00. The stock maintains a PE of 18.7700, while the industry PE is 35.6163, prompting discussions about its valuation.

Demonstrating a commendable 0.20% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,278.50. In terms of valuation, the stock maintains a PE ratio of 18.7700, while the industry PE ratio stands at 35.6163.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.03% drop, and it's now trading at ₹1,275.85 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.02% increase and currently trading at ₹1,276.00 per share. This upward trajectory is turning heads in the market.

Following a noteworthy 0.02% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,277.60. When it comes to valuation, this stock has a PE ratio of 18.7700, with the industry PE ratio at 35.6163.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.02% upswing and is currently trading at ₹1,277.60, indicating strong market sentiment.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.02% boost, with the current market value at ₹1,277.60 per share. This surge has not gone unnoticed by investors.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.04%, reaching the current market price of ₹1,277.30. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.07% boost, with the current market value at ₹1,276.40 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd's shares experienced a 0.03% uptick, and they are currently valued at ₹1,275.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

With a -0.14% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,274.70. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.7700, while the industry PE is 35.6163.

Dr Reddys Laboratories Ltd's shares experienced a 0.21% uptick, and they are currently valued at ₹1,282.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.21% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,282.00 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.09%, with its current market value per share resting at ₹1,280.80. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's share price rallied by 0.09%, reaching the current market price of ₹1,280.80. This surge is indicative of the stock's recent positive performance.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.66% boost, with the current market value at ₹1,280.85 per share. This surge has not gone unnoticed by investors.

With a -0.68% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,273.75. Investors should examine the factors driving this decline. The stock's PE ratio is 18.7700, whereas the industry PE ratio stands at 35.6163.